The knockdown of METTL14 reduced the long-term viability, migration, and invasion of BC cell lines (MDA-MB-231, MDA-MB-468, and BT549) and inhibited tumor growth in tumor xenograft models (Panneerdoss et al., 2018). The gene discussed is METTL14; the disease is breast cancer.